World of Phlebology: ControverSeas (CONG2016-20)
This activity includes the following:
Introduction
Jean-Jerome Guex, MD, FACPh
EVLA is the Best Treatment for GSV and SSV - PRO
Marlin Schul, MD, FACPh, MBA, RVT
EVAL is the Best Treatment for GSV and SSV - CON
Lars Rasmussen, MD
All Superficial Venous Thrombosis Must Be Anticoagulated - PRO
Jean Luc Gillet, MD
All Superficial Venous Thrombosis Must Be Anticoagulated - CON
Anthony Comerota, MD, FACC, FACS, RPVI, RVT
Perforating Veins Should Be Left Alone - PRO
William Marston, MD
Perforating Veins Should Be Left Alone - CON
Sergio Gianesini, MD
Commercially Prepared Sclerosing Foam is Worth the Price - PRO
Nick Morrison, MD, FACPh, FACS, RPhS
Commercially Prepared Sclerosing Foam is Worth the Price - CON
Alun Davies, MA, DM, FRCS, FEBVS
Question & Answer
All Faculty
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The primary target audience includes physicians, physician assistants and advanced registered nurse practitioners, ultrasound technologists, nurses, allied health and all other healthcare professionals currently or planning to care for patients with venous disease. Specialists focusing on phlebology, cardiology, general surgery, vascular surgery, interventional radiology, interventional cardiology, dermatology, dermatologic surgery, internal medicine, family practice, plastic surgery, obstetrics and gynecology, vascular medicine, and emergency medicine are invited to enhance their knowledge and skills specific to the treatment of venous and lymphatic disease.
Name | Role | Commercial Interest | Type of Relationship |
---|---|---|---|
Ted Chambers, MD | Content Reviewer | None | n/a |
Anthony Comerota, MD, FACC, FACS, RPVI, RVT | Speaker | 1. Merck 2. Pfizer/BMS 3. Janssen 4. Medtronic | 1. Speakers Bureau 2. Speakers Bureau 3. Consultant; Speakers Bureau 4. Consultant |
Alun Davies, MA, DM, DSc, FRCS, FEBVS | Speaker | None | n/a |
Sergio Gianesini, MD | Speaker | None | n/a |
Jean Luc Gillet, MD | Speaker | None | n/a |
Jean-Jerome Guex, MD, FACPh | Moderator; Speaker | 1. Kreussler Pharma 2. Thuasne 3. Servier Int'l. 4. Pierre Fabre 5. Vascular Insights | 1. Consultant; Speaker 2. Principal Investigator 3. Consultant; Speaker 4. Consultant; Speaker 5. Scientific Advisory Board; Shareholder |
William Marston, MD | Speaker | 1. Veniti Inc. 2. Cardinal Healthcare 3. Tactile Medical 4. Tissue Tech | 1. Principal Investigator; Steering Committee 2. Advisory Board 3. Principal Investigator; Consultant 4. Clinical Investigator |
Nick Morrison, MD, FACS, FACPh, RPhS | Speaker | 1. Medtronic 2. medi | 1. Scientific Advisory Board; Research Grant; Speakers Bureau 2. Educational Grant; Speakers Bureau |
Stephen H. Moss | Staff | None | n/a |
Lars Rasmussen, MD | Speaker | None | n/a |
Armen Roupenian, MD, FACS, RPhS, RPVI, RVT | Planner | None | n/a |
Marlin Schul, MD, FACPh, MBA, RVT | Speaker | Vein Directory | Medical Advisor Receiving Complimentary Listing |
Sonja Stiller, MD | Content Reviewer | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without the express written permission from the copyright owner.